Protein-altering germline mutations implicate novel genes related to lung cancer development.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 05 2020
Historique:
received: 12 07 2019
accepted: 25 03 2020
entrez: 13 5 2020
pubmed: 13 5 2020
medline: 15 8 2020
Statut: epublish

Résumé

Few germline mutations are known to affect lung cancer risk. We performed analyses of rare variants from 39,146 individuals of European ancestry and investigated gene expression levels in 7,773 samples. We find a large-effect association with an ATM L2307F (rs56009889) mutation in adenocarcinoma for discovery (adjusted Odds Ratio = 8.82, P = 1.18 × 10

Identifiants

pubmed: 32393777
doi: 10.1038/s41467-020-15905-6
pii: 10.1038/s41467-020-15905-6
pmc: PMC7214407
doi:

Substances chimiques

ATM protein, human EC 2.7.11.1
Ataxia Telangiectasia Mutated Proteins EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2220

Subventions

Organisme : Cancer Research UK
ID : 24390
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P50 CA119997
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA063464
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA209414
Pays : United States
Organisme : Wellcome Trust
ID : 202849/Z/16/Z
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA111703
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000117
Pays : United States
Organisme : Wellcome Trust
ID : WT202849/Z/16/Z
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P20 CA090578
Pays : United States
Organisme : NCI NIH HHS
ID : U19 CA148127
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103534
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA092824
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA197449
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA164973
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA167462
Pays : United States
Organisme : NCI NIH HHS
ID : U19 CA203654
Pays : United States
Organisme : NCRR NIH HHS
ID : P20 RR018787
Pays : United States
Organisme : Department of Health
Pays : United Kingdom
Organisme : NCRR NIH HHS
ID : S10 RR025141
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA074386
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA176568
Pays : United States
Organisme : NCI NIH HHS
ID : K07 CA172294
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA023108
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Organisme : NLM NIH HHS
ID : R56 LM012371
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA063464
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA033619
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA177558
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA090578
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA070907
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA033572
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : U01 HG004798
Pays : United States
Organisme : Medical Research Council
ID : G0902313
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA151989
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA167462
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA071789
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA164973
Pays : United States

Références

Nat Genet. 2018 Sep;50(9):1212-1218
pubmed: 30158684
N Engl J Med. 2007 Jul 12;357(2):115-23
pubmed: 17625123
Cancer Biol Ther. 2007 Mar;6(3):308-12
pubmed: 17387266
Nat Rev Dis Primers. 2015 May 21;1:15009
pubmed: 27188576
Nature. 2008 Oct 23;455(7216):1069-75
pubmed: 18948947
Arthritis Rheum. 1991 Nov;34(11):1416-24
pubmed: 1683235
Cell. 2018 Apr 5;173(2):355-370.e14
pubmed: 29625052
CA Cancer J Clin. 2017 Nov;67(6):493-506
pubmed: 28881380
PLoS One. 2013 Dec 06;8(12):e82769
pubmed: 24324828
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
N Engl J Med. 2008 Jan 31;358(5):502-11
pubmed: 18234754
Nat Biotechnol. 2004 Oct;22(10):1302-6
pubmed: 15361882
Nat Commun. 2018 Aug 13;9(1):3221
pubmed: 30104567
Expert Rev Anticancer Ther. 2009 Apr;9(4):389-92
pubmed: 19374592
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13790-5
pubmed: 11707567
Nucleic Acids Res. 2012 Jan;40(Database issue):D935-9
pubmed: 22075996
JAMA. 2016 Jan 5;315(1):68-76
pubmed: 26746459
Carcinogenesis. 2016 Jan;37(1):96-105
pubmed: 26590902
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780
Asian Pac J Cancer Prev. ;18(11):3003-3009
pubmed: 29172272
BMC Genomics. 2017 Oct 16;18(1):789
pubmed: 29037167
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
J Thorac Oncol. 2014 Apr;9(4):456-63
pubmed: 24736066
Ann Oncol. 2014 Feb;25(2):423-8
pubmed: 24478319
Nat Genet. 2017 Jul;49(7):1126-1132
pubmed: 28604730
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):
pubmed: 24003211
JAMA. 2014 Sep 17;312(11):1091-2
pubmed: 25198398
Isr Med Assoc J. 2019 Mar;21(3):194-197
pubmed: 30905106
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103

Auteurs

Xuemei Ji (X)

Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. xuemei.ji@yahoo.com.

Semanti Mukherjee (S)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Maria Teresa Landi (MT)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Yohan Bosse (Y)

Institut universitaire de cardiologie et de pneumologie de Québec, Department of Molecular Medicine, Laval University, Québec, Canada.

Philippe Joubert (P)

Institut universitaire de cardiologie et de pneumologie de Québec, Department of Molecular Medicine, Laval University, Québec, Canada.

Dakai Zhu (D)

Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
The Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.

Ivan Gorlov (I)

Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

Xiangjun Xiao (X)

The Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.

Younghun Han (Y)

The Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.

Olga Gorlova (O)

Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

Rayjean J Hung (RJ)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto, Toronto, Canada.

Yonathan Brhane (Y)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto, Toronto, Canada.

Robert Carreras-Torres (R)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

David C Christiani (DC)

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Medicine, Massachusetts General Hospital/Harvard, Boston, MA, USA.

Neil Caporaso (N)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Mattias Johansson (M)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Geoffrey Liu (G)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto, Toronto, Canada.

Stig E Bojesen (SE)

Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark.

Loic Le Marchand (L)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.

Demetrios Albanes (D)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Heike Bickeböller (H)

Department of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, Göttingen, Germany.

Melinda C Aldrich (MC)

Department of Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center, Göttingen, Germany.

William S Bush (WS)

Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.

Adonina Tardon (A)

IUOPA. University of Oviedo and CIBERESP, Faculty of Medicine, Campus del Cristo s/n, Oviedo, Spain.

Gad Rennert (G)

Clalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.

Chu Chen (C)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Jinyoung Byun (J)

The Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.

Konstantin H Dragnev (KH)

The Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

John K Field (JK)

Roy Castle lung Cancer Research Programme, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.

Lambertus Fa Kiemeney (LF)

Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.

Philip Lazarus (P)

Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, WA, USA.

Shan Zienolddiny (S)

National Institute of Occupational Health, Oslo, Norway.

Stephen Lam (S)

British Columbia Cancer Agency, Vancouver, Canada.

Matthew B Schabath (MB)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Angeline S Andrew (AS)

Department of Epidemiology, Geisel School of Medicine, Hanover, NH, USA.

Pier A Bertazzi (PA)

Department of Preventive Medicine, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Angela C Pesatori (AC)

Department of Preventive Medicine, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Nancy Diao (N)

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Li Su (L)

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Lei Song (L)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Ruyang Zhang (R)

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Natasha Leighl (N)

University Health Network- The Princess Margaret Cancer Centre, Toronto, CA, USA.

Jakob S Johansen (JS)

Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.

Anders Mellemgaard (A)

Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.

Walid Saliba (W)

Clalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.

Christopher Haiman (C)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

Lynne Wilkens (L)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.

Ana Fernandez-Somoano (A)

IUOPA. University of Oviedo and CIBERESP, Faculty of Medicine, Campus del Cristo s/n, Oviedo, Spain.

Guillermo Fernandez-Tardon (G)

IUOPA. University of Oviedo and CIBERESP, Faculty of Medicine, Campus del Cristo s/n, Oviedo, Spain.

Erik H F M van der Heijden (EHFMV)

Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.

Jin Hee Kim (JH)

Department of Integrative Bioscience & Biotechnology, Sejong University, Gwangjin-gu, Seoul, Republic of Korea.

Michael P A Davies (MPA)

Roy Castle lung Cancer Research Programme, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.

Michael W Marcus (MW)

Roy Castle lung Cancer Research Programme, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.

Hans Brunnström (H)

Department of Pathology, Lund University, Lund, Sweden.

Jonas Manjer (J)

Faculty of Medicine, Lund University, Lund, Sweden.

Olle Melander (O)

Faculty of Medicine, Lund University, Lund, Sweden.

David C Muller (DC)

School of Public Health, St Mary's Campus, Imperial College London, London, UK.

Kim Overvad (K)

Faculty of Medicine, Lund University, Lund, Sweden.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, GR, Greece.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, "Civic - M.P. Arezzo" Hospital, Asp Ragusa, Italy.

Gary E Goodman (GE)

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Swedish Medical Group, Seattle, WA, USA.

Angela Cox (A)

Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.

Fiona Taylor (F)

Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.

Penella Woll (P)

Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.

Erich Wichmann (E)

Research Unit of Molecular Epidemiology, Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.

Thomas Muley (T)

Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany.

Angela Risch (A)

University of Salzburg and Cancer Cluster Salzburg, Salzburg, Austria.

Albert Rosenberger (A)

Department of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, Göttingen, Germany.

Kjell Grankvist (K)

Department of Medical Biosciences, Umeå University, Umeå, Sweden.

Mikael Johansson (M)

Department of Radiation Sciences, Umeå University, Umeå, Sweden.

Frances Shepherd (F)

Princess Margaret Cancer Centre, Toronto, Canada.

Ming-Sound Tsao (MS)

Princess Margaret Cancer Centre, Toronto, Canada.

Susanne M Arnold (SM)

University of Kentucky, Markey Cancer Center, Lexington, KY, USA.

Eric B Haura (EB)

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Ciprian Bolca (C)

Institute of Pneumology "Marius Nasta", Bucharest, Romania.

Ivana Holcatova (I)

Charles University, 1st Faculty of Medicine, Prague, Czech Republic.

Vladimir Janout (V)

Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.

Milica Kontic (M)

Clinical Center of Serbia, Clinic for Pulmonology, School of Medicine, University of Belgrade, Belgrade, Serbia.

Jolanta Lissowska (J)

Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.

Anush Mukeria (A)

Department of Epidemiology and Prevention, Russian N.N.Blokhin Cancer Research Centre, Moscow, Russian Federation.

Simona Ognjanovic (S)

International Organization for Cancer Prevention and Research, Belgrade, Serbia.

Tadeusz M Orlowski (TM)

Department of Surgery, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.

Ghislaine Scelo (G)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Beata Swiatkowska (B)

Nofer Institute of Occupational Medicine, Department of Environmental Epidemiology, Lodz, Poland.

David Zaridze (D)

Department of Epidemiology and Prevention, Russian N.N.Blokhin Cancer Research Centre, Moscow, Russian Federation.

Per Bakke (P)

Department of Clinical Science, University of Bergen, Bergen, Norway.

Vidar Skaug (V)

National Institute of Occupational Health, Oslo, Norway.

Lesley M Butler (LM)

University of Pittsburgh Cancer Institute, Pittsburgh, USA.

Kenneth Offit (K)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Preethi Srinivasan (P)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.

Chaitanya Bandlamudi (C)

Marie-Josée and Henry R. KravisCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.

Matthew D Hellmann (MD)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

David B Solit (DB)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Marie-Josée and Henry R. KravisCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.

Mark E Robson (ME)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Charles M Rudin (CM)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Zsofia K Stadler (ZK)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Barry S Taylor (BS)

Marie-Josée and Henry R. KravisCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA.

Michael F Berger (MF)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
Marie-Josée and Henry R. KravisCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.

Richard Houlston (R)

The Institute of Cancer Research, London, UK.

John McLaughlin (J)

University of Toronto, Toronto, Canada.

Victoria Stevens (V)

American Cancer Society, Inc., Atlanta, GA, USA.

David C Nickle (DC)

Merck Research Laboratories, Genetics and Pharmacogenomics, Boston, MA, USA.

Ma'en Obeidat (M)

The University of British Columbia Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.

Wim Timens (W)

University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, GRIAC research institute, Groningen, The Netherlands.

María Soler Artigas (MS)

Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, LE1 7RH, UK.
National Institute for Health Research (NIHR) Leicester Respiratory Biomedical Research Unit, Glenfield Hospital, Leicester, UK.

Sanjay Shete (S)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Stephen Chanock (S)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Paul Brennan (P)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

James D McKay (JD)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Christopher I Amos (CI)

The Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA. chrisa@bcm.edu.
Dan L Duncan Comprehensive Cancer Center, 7200 Cambridge St., 7th Floor, Houston, TX, 77030, USA. chrisa@bcm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH